Xylem Inc (XYL)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Net income (ttm) US$ in thousands 962,000 788,000 663,000 609,000 492,000 352,000 372,000 355,000 319,000 421,000 422,000 427,000 462,000 385,000 303,000 254,000 224,000 252,000 360,000 401,000
Total stockholders’ equity US$ in thousands 10,642,000 10,593,000 10,195,000 10,166,000 9,930,000 9,899,000 3,578,000 3,494,000 3,215,000 3,195,000 3,198,000 3,218,000 3,093,000 3,040,000 2,937,000 2,968,000 2,867,000 2,856,000 2,812,000 2,957,000
ROE 9.04% 7.44% 6.50% 5.99% 4.95% 3.56% 10.40% 10.16% 9.92% 13.18% 13.20% 13.27% 14.94% 12.66% 10.32% 8.56% 7.81% 8.82% 12.80% 13.56%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $962,000K ÷ $10,642,000K
= 9.04%

Xylem Inc's Return on Equity (ROE) has shown some fluctuations over the period from December 31, 2019, to December 31, 2024. The trend exhibited a decline from 13.56% on December 31, 2019, to a low point of 3.56% on June 30, 2023, before gradually recovering.

The ROE decreased from 13.56% on December 31, 2019, to 7.81% on September 30, 2020, and further dropped to 3.56% on June 30, 2023, reflecting a challenging period during this timeframe. However, the ROE recovered thereafter, reaching a peak of 14.94% on September 30, 2021. Subsequently, it stabilized around the range of 10-13% for the most part until the end of 2024.

Overall, the ROE performance of Xylem Inc experienced volatility but demonstrated resilience by climbing back to 9.04% by December 31, 2024. This suggests that the company managed to improve its ability to generate profit from shareholders' equity compared to the low point in mid-2023. Further analysis would be needed to understand the factors driving these fluctuations and assess the sustainability of the company's ROE going forward.